Stock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Stock Performance Shares of NYSE CANF opened at $2.09 on Tuesday. The company has a market capitalization […]